OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Multiple treatment comparison in narcolepsy: a network meta-analysis
Philippe Lehert, Bruno Falissard
SLEEP (2018) Vol. 41, Iss. 12
Open Access | Times Cited: 38
Philippe Lehert, Bruno Falissard
SLEEP (2018) Vol. 41, Iss. 12
Open Access | Times Cited: 38
Showing 1-25 of 38 citing articles:
Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment
Claudio L. Bassetti, Antoine Adamantidis, Denis Burdakov, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 9, pp. 519-539
Closed Access | Times Cited: 492
Claudio L. Bassetti, Antoine Adamantidis, Denis Burdakov, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 9, pp. 519-539
Closed Access | Times Cited: 492
Long-term use of pitolisant to treat patients with narcolepsy: Harmony III Study
Yves Dauvilliers, Isabelle Arnulf, Zoltán Szakács, et al.
SLEEP (2019) Vol. 42, Iss. 11
Open Access | Times Cited: 230
Yves Dauvilliers, Isabelle Arnulf, Zoltán Szakács, et al.
SLEEP (2019) Vol. 42, Iss. 11
Open Access | Times Cited: 230
Pitolisant: A Review in Narcolepsy with or without Cataplexy
Yvette N. Lamb
CNS Drugs (2020) Vol. 34, Iss. 2, pp. 207-218
Closed Access | Times Cited: 201
Yvette N. Lamb
CNS Drugs (2020) Vol. 34, Iss. 2, pp. 207-218
Closed Access | Times Cited: 201
Comparative efficacy, safety and benefit/risk of alerting agents for excessive daytime sleepiness in patients with obstructive sleep apnoea: a network meta-analysis
Jean‐Louis Pépin, Philippe Lehert, Raoua Ben Messaoud, et al.
EClinicalMedicine (2024) Vol. 76, pp. 102843-102843
Open Access | Times Cited: 4
Jean‐Louis Pépin, Philippe Lehert, Raoua Ben Messaoud, et al.
EClinicalMedicine (2024) Vol. 76, pp. 102843-102843
Open Access | Times Cited: 4
Pitolisant versus placebo for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: A meta-analysis from randomized controlled trials
Jiahe Wang, Xiang Li, Siyuan Yang, et al.
Pharmacological Research (2021) Vol. 167, pp. 105522-105522
Closed Access | Times Cited: 21
Jiahe Wang, Xiang Li, Siyuan Yang, et al.
Pharmacological Research (2021) Vol. 167, pp. 105522-105522
Closed Access | Times Cited: 21
Comparative Efficacy and Safety of Multiple Wake-Promoting Agents for the Treatment of Excessive Daytime Sleepiness in Narcolepsy: A Network Meta-Analysis
Shuqin Zhan, Hui Ye, Ning Li, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 217-230
Open Access | Times Cited: 8
Shuqin Zhan, Hui Ye, Ning Li, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 217-230
Open Access | Times Cited: 8
Efficacy and safety of solriamfetol for excessive sleepiness in narcolepsy and obstructive sleep apnea: findings from randomized controlled trials
Jiahe Wang, Siyuan Yang, Xiang Li, et al.
Sleep Medicine (2021) Vol. 79, pp. 40-47
Closed Access | Times Cited: 18
Jiahe Wang, Siyuan Yang, Xiang Li, et al.
Sleep Medicine (2021) Vol. 79, pp. 40-47
Closed Access | Times Cited: 18
Efficacy and safety of solriamfetol for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a systematic review and meta-analysis of clinical trials
Roshan Subedi, Rajshree Singh, Rahul Thakur, et al.
Sleep Medicine (2020) Vol. 75, pp. 510-521
Closed Access | Times Cited: 20
Roshan Subedi, Rajshree Singh, Rahul Thakur, et al.
Sleep Medicine (2020) Vol. 75, pp. 510-521
Closed Access | Times Cited: 20
<p>Pitolisant to Treat Excessive Daytime Sleepiness and Cataplexy in Adults with Narcolepsy: Rationale and Clinical Utility</p>
Jay Guevarra, Robert Hiensch, Andrew W. Varga, et al.
Nature and Science of Sleep (2020) Vol. Volume 12, pp. 709-719
Open Access | Times Cited: 19
Jay Guevarra, Robert Hiensch, Andrew W. Varga, et al.
Nature and Science of Sleep (2020) Vol. Volume 12, pp. 709-719
Open Access | Times Cited: 19
Usefulness of the maintenance of wakefulness test in central disorders of hypersomnolence: a scoping review
Denise Bijlenga, Sebastiaan Overeem, Rolf Fronczek, et al.
SLEEP (2022) Vol. 45, Iss. 8
Open Access | Times Cited: 11
Denise Bijlenga, Sebastiaan Overeem, Rolf Fronczek, et al.
SLEEP (2022) Vol. 45, Iss. 8
Open Access | Times Cited: 11
Pitolisant for treating patients with narcolepsy
Shuang Li, Junyi Yang
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 2, pp. 79-84
Closed Access | Times Cited: 16
Shuang Li, Junyi Yang
Expert Review of Clinical Pharmacology (2020) Vol. 13, Iss. 2, pp. 79-84
Closed Access | Times Cited: 16
An evaluation of sodium oxybate as a treatment option for narcolepsy
Vivien C. Abad
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 10, pp. 1189-1199
Closed Access | Times Cited: 17
Vivien C. Abad
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 10, pp. 1189-1199
Closed Access | Times Cited: 17
Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know
Lois E. Krahn, Phyllis C. Zee, Michael J. Thorpy
Advances in Therapy (2021) Vol. 39, Iss. 1, pp. 221-243
Open Access | Times Cited: 14
Lois E. Krahn, Phyllis C. Zee, Michael J. Thorpy
Advances in Therapy (2021) Vol. 39, Iss. 1, pp. 221-243
Open Access | Times Cited: 14
Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy
Junyi Yang, Junfa Gao
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 8, pp. 723-728
Closed Access | Times Cited: 15
Junyi Yang, Junfa Gao
Expert Review of Clinical Pharmacology (2019) Vol. 12, Iss. 8, pp. 723-728
Closed Access | Times Cited: 15
Evaluating pitolisant as a narcolepsy treatment option
Stefano de Biase, Gaia Pellitteri, Gian Luigi Gigli, et al.
Expert Opinion on Pharmacotherapy (2020) Vol. 22, Iss. 2, pp. 155-162
Closed Access | Times Cited: 11
Stefano de Biase, Gaia Pellitteri, Gian Luigi Gigli, et al.
Expert Opinion on Pharmacotherapy (2020) Vol. 22, Iss. 2, pp. 155-162
Closed Access | Times Cited: 11
How treatable is narcolepsy with current pharmacotherapy and what does the future hold?
Gaia Pellitteri, Stefano de Biase, Mariarosaria Valente, et al.
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 12, pp. 1517-1520
Closed Access | Times Cited: 7
Gaia Pellitteri, Stefano de Biase, Mariarosaria Valente, et al.
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 12, pp. 1517-1520
Closed Access | Times Cited: 7
Pharmacological Interventions for Excessive Daytime Sleepiness in Adults with Narcolepsy: A Systematic Review and Network Meta-Analysis
Po-Yu Chien, Chan‐Yen Kuo, Meng-Hsuan Lin, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6302-6302
Open Access | Times Cited: 5
Po-Yu Chien, Chan‐Yen Kuo, Meng-Hsuan Lin, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 21, pp. 6302-6302
Open Access | Times Cited: 5
Comparison of modafinil and pitolisant in narcolepsy: a non-inferiority metaanalytical approach
Philippe Lehert, Cassandra Szoeke
Drugs in Context (2020) Vol. 9, pp. 1-13
Open Access | Times Cited: 7
Philippe Lehert, Cassandra Szoeke
Drugs in Context (2020) Vol. 9, pp. 1-13
Open Access | Times Cited: 7
Clinical Characteristics of Cataplectic Attacks in Type 1 Narcolepsy
Arpita Parmar, Brian J. Murray, Indra Narang
Current Neurology and Neuroscience Reports (2020) Vol. 20, Iss. 9
Closed Access | Times Cited: 6
Arpita Parmar, Brian J. Murray, Indra Narang
Current Neurology and Neuroscience Reports (2020) Vol. 20, Iss. 9
Closed Access | Times Cited: 6
Efficacy of Pitolisant 20 mg in Reducing Excessive Daytime Sleepiness and Fatigue in Patients with Obstructive Sleep Apnoea Syndrome: An Individual Patient Data Meta-analysis
Philippe Lehert
Clinical Drug Investigation (2021) Vol. 42, Iss. 1, pp. 65-74
Open Access | Times Cited: 6
Philippe Lehert
Clinical Drug Investigation (2021) Vol. 42, Iss. 1, pp. 65-74
Open Access | Times Cited: 6
Calcium, magnesium, potassium, and sodium oxybates oral solution for cataplexy or excessive daytime sleepiness associated with narcolepsy
Vivien C. Abad
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 8, pp. 875-885
Closed Access | Times Cited: 2
Vivien C. Abad
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 8, pp. 875-885
Closed Access | Times Cited: 2
The therapeutic potential of opioids in narcolepsy type 1: A systematic literature review and questionnaire study
Jari K. Gool, Eva M. van Heese, Mink S. Schinkelshoek, et al.
Sleep Medicine (2023) Vol. 109, pp. 118-127
Open Access | Times Cited: 2
Jari K. Gool, Eva M. van Heese, Mink S. Schinkelshoek, et al.
Sleep Medicine (2023) Vol. 109, pp. 118-127
Open Access | Times Cited: 2
Rate of elimination of γ-hydroxybutyrate from blood determined by analysis of two consecutive samples from apprehended drivers in Norway
M. Cruz Arnés, Liliana Bachs, Mohammad Al Sammarai, et al.
Forensic Science International (2020) Vol. 314, pp. 110374-110374
Open Access | Times Cited: 5
M. Cruz Arnés, Liliana Bachs, Mohammad Al Sammarai, et al.
Forensic Science International (2020) Vol. 314, pp. 110374-110374
Open Access | Times Cited: 5
Narcolepsy management in Australia: time to wake up
Sheila Sivam, Ksenia Chamula, John Swieca, et al.
The Medical Journal of Australia (2021) Vol. 215, Iss. 2, pp. 62-62
Closed Access | Times Cited: 5
Sheila Sivam, Ksenia Chamula, John Swieca, et al.
The Medical Journal of Australia (2021) Vol. 215, Iss. 2, pp. 62-62
Closed Access | Times Cited: 5
The promise of mindfulness-based interventions for narcolepsy
Michael Mak, Mary Preisman
SLEEP (2024) Vol. 47, Iss. 10
Closed Access
Michael Mak, Mary Preisman
SLEEP (2024) Vol. 47, Iss. 10
Closed Access
